Reply.io Revenue and Competitors

Claim your profile

Toronto, ON CAN

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Reply.io's estimated annual revenue is currently $12.9M per year.(i)
  • Reply.io's estimated revenue per employee is $145,000
  • Reply.io's pricing is $660 per year.

Employee Data

  • Reply.io has 89 Employees.(i)
  • Reply.io grew their employee count by 24% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$307.7M153749%$489M$4.4B
#2
$2M20N/AN/AN/A
#3
$0.9M7N/AN/AN/A
#4
$1180M753638%$100.5M$21.8B
#5
$1.6M19N/AN/AN/A
#6
$6.2M9429%N/AN/A
#7
$201.2M1-100%$245.7M$1.1B
#8
$0.5M16129%$1.7MN/A
#9
$4.9M42N/AN/AN/A
#10
$1.4M16N/AN/AN/A
#11
$2.2M22N/AN/AN/A
#12
$3.9M34N/AN/AN/A
#13
$5.5M47N/AN/AN/A
#14
$8.8M34-3%N/AN/A
#15
$1M11N/AN/AN/A
#16
$0.5M7N/AN/AN/A
#17
$88.7M499-8%$162.8MN/A
#18
$0.5M7N/AN/AN/A
#19
$0.2M3N/AN/AN/A
#20
$1.5M10N/AN/AN/A

Reply automates one-to-many communication for you and your team - dramatically scaling your outreach capability, while keeping it 100% personal. Reply began it's journey in August 2014. We noticed that world of direct sales is changing dramatically. With data available online it became possible to find right people at the right time, when they need your product. Honest and supportive sales teams come in place, replacing old school pushy sales with their low effective cold call approach. And here, at Reply, we are striving to build the best sales acceleration platform that would allow new type of sales teams perform on their best.

keywords:SaaS

N/A

Total Funding

89

Number of Employees

$12.9M

Revenue (est)

24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Reply.io News

2022-04-20 - Theft from Sonam’s house: Bail denied

The IO's reply indicates that some other expensive jewels are yet to be recovered from the accused, the court noted. TNN.

2022-04-17 - B2b Sales Intelligence Software? – ictsd.org

Reply.io. AeroLeads. How Do I Find Leads For Sales? Referrals can be found from current customers. Find sales leads...

2022-03-22 - Merck, building on Keytruda's landmark biomarker nod ...

... biomarker nod, pressures GSK's limited I-O position with new FDA approval ... The tumor response showing marks a slight improvement from the 36%...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.7M896%N/A
#2
$18.7M89-1%N/A
#3
$24M8975%N/A
#4
$24M8913%N/A
#5
$19.6M8927%$113.3M